ADHD Homeopathic Study

I was pleased to find an ADHD Homeopathic Study with 36 children suffering with ADHD.  On reading the details I find it so difficult to ever see how homeopathy can be compared to the clinical trials of mainstream medicine, it's like putting a square peg into a round hole.   But it is good to hear that these studies are being researched and recorded.

First of all the objectives of the study were to see if particular remedies could be prescribed to children with ADHD ..... but this is not how homeopathy works.

Second the children were given mainstream medications at the same time as homeopathic remedies and their medications were often changed through the study .... to me this cannot give true results from homeopathic applications.  I wonder how they would view this if patients took homeopathic remedies whilst conducting mainstream medicine trials.

Anyway ... my views apart .. it is great that these trials are being conducted, that homeopathy can be seen as having had the clinical trials and recordings and that homeopathy is being acknowledged as an alternative medication.

For me of course, the most important detail is seeing the range of remedies used in the trial.  I will follow this up with more information on some of these remedies so you can see how they can be used for particular symptoms and emotional reactions.

Homeopathic Medicines Used

Below are the homeopathic medicines used and the frequency as well as the number of times the remedy was chosen prior to significant improvement (in brackets). All medicines were used individually.

Phosphorus, Hyoscyamus niger, Tuberculinum, Tarentula hispanica, Lycopodium clavatum, Anacardium orientale, Lachesis muta, Stramonium, Veratrum album, Lac caninum, Nux vomica, Pulsatilla, Belladonna, Saccharum officinalis, Calcarea phophorica, Aconitum, Aranea ixabola, Gallicum acidum, Natrum muriaticum, Agnus castus, Agaricus muscarius, Apis mellifica, Baryta carbonica, Bryonia alba, Bufo rana, Calcarea carbonica, Cuprum metallicum, Ferrum phosphoricum, Hepar sulphuris calcareum, Kalium phosphoricum, Luesinum, Magnesium carbonica, Medorrhinum, Natrum silicata, Silicea, Staphysagria, Sulphur, Thuja occidentalis, Veratrum viride.

Some of the remedies are suitable to try for home prescribing, others should be taken with the support of your homeopath.   This is because deep acting remedies work through the health history exposing deeper issue which may need to be supported through treatment.

Learning more about working with a homeopath

Book a FREE 15 min consultation to find out how homeopathy can help you and your family

Here is the summary of the trial:

Background: An open-label pilot study of individualized homeopathy for attention deficit hyperactivity disorder (ADHD) was conducted to assess the potential for future studies with a focus on the feasibility of the recruitment plan and outcome measure schedules; identification of any group characteristics of participants who respond significantly to the therapy; and establishing the length of time required for an improvement in ADHD symptoms. 

Patients and Methods: Participants (aged 6-16) were recruited through community advertisement and outreach.

Participants completed 1 screening and 9 individualized homeopathic follow-up consultations. ADHD symptoms were assessed using the Conners 3 - Parent Questionnaire administered at each consultation.

The pre- and post-study difference in Conners Global Index - Parent (CGI-P) T-score was evaluated for each participant.

Baseline data of those who showed a statistically significant improvement (responders) were compared to those who did not (non-responders). 

Results: 35 participants were enrolled over 11 months.

80% completed all 10 consultations in a median of 12.1 months.
63% had a statistically significant improvement in the primary outcome, first occurring after a mean of 4.5 visits.
Overall scores for participants completing at least 2 data points decreased from a baseline median of 85.5 to 74.0 (p < 0.001, CI 95%). There were no significant baseline differences between responders and non-responders.
No serious adverse events related to the therapy were reported. 

Conclusion: The change in the median CGI-P T-score from baseline to the end of this open-label pilot study was statistically significant. The research methods are feasible. Future studies are warranted. Trial registration: 

Symptoms recorded
Oppositional behaviour, defiance, argumentativeness
Anger, loss of temper, tantrums
Sleep problems
Violence, aggression, bullying
Hyperactivity
Disruptive behaviour
Clinginess, sensitivity
Emotional volatility
Inattentiveness
Nervousness
Appetite / digestion
Headaches
Nosebleeds
Nose/throat discomfort
Shaking limbs
Self inflicted injury
Blood/red spots on face, chest and arms

Timeline of Response

For participants classified as responders, a statistically significant improvement in CGI-P T-score first occurred after a mean of 4.5 visits (SD = 2.67) and 4.6 months (SD = 4.03).

For details of the study click through here.

Comments are closed.

CLOSE
CLOSE